Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Limited was originally incorporated as a private limited Company as 'Star Imaging & Path Lab Private Limited' dated May 31, 2004, issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, it converted into a Public Company and the name of the Company was changed to 'Star Imaging and Path Lab Limited' on September 17, 2024 issued by Central Processing Centre. The Company started its journey from 1978 as proprietorship under the name of Janta X-Ray Clinic and were providing X-ray and basic pathology tests using manual methods. Over the years, they have upgraded their services, equipment, and diagnostic technologies to incorporate latest advancements in medical science, ensuring the care and improved patient outcomes. This vision led to establishment of Star Imaging & Path Lab Private Limited in 2004, as Private Limited entity, to offer pathology, radiology, Cardiology, and Neurology services under one roof. As part of expansion, Company acquired the businesses of Janta X-Ray Clinic, M/s Star Imaging & Path Lab, and M/s Star Health Care, in 2011. It formed a Subsidiary in the name of 'Staredu Education and Training Institute Private Limited' to expand business activities in 2017. At present, Company operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi (B2C, B2B & B2G model), Uttar Pradesh (B2G model), and Nasik (B2G Model) regions of India. It offer a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography. In the pathology segment, services include biochemistry, hematology, clinical pathology, histopathology, cytopathology, microbiology, serology, and immunology. Apart from these, the Company also operate a tele-radiology hub, with a full suite of diagnostic imaging equipment and supported by a skilled team of radiologists. This centralized facility provides significant operational efficiencies and scalability, ensuring quality diagnostic services have been delivered consistently across the network. The Company raised Rs 69.47 Cr through IPO, by issuing 48,92,000 equity shares of Rs 10/- each, comprising a fresh issue of 39,20,000 equity shares aggregating to Rs 55.66 Cr and offer for sale of 9,72,000 equity shares aggregating to Rs 13.80 Cr in August, 2025.